⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GPCR News
Structure Therapeutics Inc. American Depositary Shares
Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron
globenewswire.com
GPCR
Structure Therapeutics to Report Data from ACCESS Clinical Program of Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron, on December 8, 2025
globenewswire.com
GPCR
Structure Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
globenewswire.com
GPCR